NCT/Study#
NCT06585774 /
INCA34176-357
Phase 3 Study of Axatilimab (INCA034176) and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease (INCA34176-357).
DISEASE GROUP:
Bone Marrow Transplant
current phase:
Phase III
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
